Metabolic comorbidities affect the survival of hepatitis B virus-related hepatocellular carcinoma in Chinese patients: a retrospective cohort study with propensity score matching - Scorecard - MDSpire
Advertisement
Metabolic comorbidities affect the survival of hepatitis B virus-related hepatocellular carcinoma in Chinese patients: a retrospective cohort study with propensity score matching
Clinical Scorecard: Impact of Metabolic Comorbidities on Survival Outcomes in Chinese Patients with Hepatitis B Virus-Associated Hepatocellular Carcinoma: A Retrospective Cohort Analysis Utilizing Propensity Score Matching
At a Glance
Category
Detail
Condition
Hepatitis B Virus-Associated Hepatocellular Carcinoma
Key Mechanisms
Metabolic comorbidities including type 2 diabetes mellitus, hypertension, and low high-density lipoprotein levels impact overall survival.
Target Population
Chinese patients with HBV-related HCC
Care Setting
Retrospective cohort study in multiple hospitals
Key Highlights
Overall survival was significantly worse in patients with metabolic comorbidities compared to those without.
Type 2 diabetes mellitus was identified as an independent risk factor for overall survival.
The presence of multiple metabolic comorbidities was associated with worse prognosis.
Intrahepatic multifocal lesions were more prevalent in patients with metabolic comorbidities.
The study utilized propensity score matching to analyze survival outcomes.
Guideline-Based Recommendations
Diagnosis
Diagnosis of hepatocellular carcinoma based on postoperative pathological results or clinical diagnostic criteria.
Management
Follow-up with imaging and alpha-fetoprotein testing after treatment.
Monitoring & Follow-up
Regular follow-up using enhanced CT, MRI, and AFP at specified intervals.
Risks
Increased risk of poor overall survival associated with metabolic comorbidities.
Patient & Prescribing Data
Patients diagnosed with HBV-related hepatocellular carcinoma.
Management strategies should consider the presence of metabolic comorbidities.
Clinical Best Practices
Assess for metabolic comorbidities in patients with HBV-related HCC.
Utilize a multidisciplinary approach for managing patients with multiple comorbidities.
